WallStSmart

Bon Natural Life Ltd (BON)vsSherwin-Williams Co (SHW)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 132280% more annual revenue ($24.91B vs $18.82M). SHW leads profitability with a 10.7% profit margin vs -60.4%. SHW earns a higher WallStSmart Score of 56/100 (C).

BON

Avoid

31

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 2/9Altman Z: 1.99

SHW

Buy

56

out of 100

Grade: C

Growth: 4.7Profit: 8.0Value: 4.7Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BON.

SHWUndervalued (+1.7%)

Margin of Safety

+1.7%

Fair Value

$338.23

Current Price

$340.92

$2.69 discount

UndervaluedFair: $338.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BON2 strengths · Avg: 9.5/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

SHW3 strengths · Avg: 9.0/10
Return on EquityProfitability
69.7%10/10

Every $100 of equity generates 70 in profit

Market CapQuality
$80.35B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

Areas to Watch

BON4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Market CapQuality
$9.31M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SHW4 concerns · Avg: 4.0/10
PEG RatioValuation
2.144/10

Expensive relative to growth rate

P/E RatioValuation
30.6x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
0.9%4/10

0.9% earnings growth

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BON

The strongest argument for BON centers on Price/Book, Debt/Equity.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap, Free Cash Flow.

Bear Case : BON

The primary concerns for BON are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, EPS Growth. Debt-to-equity of 3.69 is elevated, increasing financial risk.

Key Dynamics to Monitor

BON profiles as a turnaround stock while SHW is a value play — different risk/reward profiles.

SHW carries more volatility with a beta of 1.08 — expect wider price swings.

SHW is growing revenue faster at 7.9% — sustainability is the question.

SHW generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

SHW scores higher overall (56/100 vs 31/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bon Natural Life Ltd

BASIC MATERIALS · SPECIALTY CHEMICALS · China

Bon Natural Life Limited is dedicated to the research and development, manufacture and sale of functional active ingredients extracted from natural herbal plants. The company is headquartered in Cayman Islands.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?